KRUKAR, Katarzyna Maria et al. Clinical use of Abemaciclib a cyclin-dependent kinase (CDK) 4/6 inhibitor in patients with breast cancer — literature review. Journal of Education, Health and Sport, [S. l.], v. 68, p. 55282, 2024. DOI: 10.12775/JEHS.2024.68.55282. Disponível em: https://apcz.umk.pl/JEHS/article/view/55282. Acesso em: 8 jul. 2025.